Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A group sequential, response-adaptive design for randomized clinical trials.

Theodore G Karrison1, Dezheng Huo, Rick Chappell

  • 1Department of Health Studies, University of Chicago, Chicago, Illinois 60637, USA. tkarrison@health.bsd.uchicago.edu

Controlled Clinical Trials
|September 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polygenic Risk Scores for Breast Cancer Among African American Women With High Risk.

JAMA network open·2026
Same author

Contextualizing the Utility of Polygenic Risk Scores using Absolute Risk Models in Diverse Ancestry Populations.

medRxiv : the preprint server for health sciences·2026
Same author

Birth Cohort Effects on Colorectal Cancer Onset in Lynch Syndrome.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Multi-ancestry transcriptome-wide association studies uncover insights into breast cancer genetics and biology.

Nature communications·2026
Same author

Estimating Baseline Survival Function in the Proportional Hazards Model Under Monotone Hazards.

Journal of statistical theory and practice·2026
Same author

Accessible Clinical Tool for Prognosis and Chemotherapy Prediction in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer in Diverse and Low-Resource Settings.

JCO global oncology·2026
Same journal

On the generation and ownership of alpha in medical studies.

Controlled clinical trials·2004
Same journal

An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.

Controlled clinical trials·2004
Same journal

Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture.

Controlled clinical trials·2004
Same journal

Statistical comparison of random allocation methods in cancer clinical trials.

Controlled clinical trials·2004
Same journal

Analyzing bronchodilation with emphasis on disease type, age and sex.

Controlled clinical trials·2004
Same journal

Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.

Controlled clinical trials·2004
See all related articles

This study introduces a novel response-adaptive design for clinical trials with binary outcomes, improving efficiency and reducing bias. The adaptive strategy maintains type I error rates and can decrease patients on inferior treatments, especially with large effects.

Area of Science:

  • Clinical Trial Methodology
  • Biostatistics
  • Adaptive Clinical Trials

Background:

  • Response-adaptive designs offer methodological advantages but are rarely used due to logistical challenges and potential bias.
  • Existing group sequential designs address some concerns but often focus on continuous outcomes.
  • Bias can arise from patient selection, characteristic drift, and other time-varying factors.

Purpose of the Study:

  • To develop and evaluate a response-adaptive design for clinical trials with binary outcomes.
  • To implement an algorithm that adjusts treatment allocation ratios based on accumulating evidence.
  • To assess the design's ability to maintain type I error rates and manage bias.

Main Methods:

  • Patients are enrolled in sequential groups with adaptive allocation ratios based on interim analysis of treatment outcomes.

Related Experiment Videos

  • The allocation ratio (1:1, R(1), R(2), R(3)) is adjusted based on the z-statistic comparing treatment groups.
  • The z-statistic is derived from a weighted log-odds ratio stratified by sequential group; O'Brien-Fleming boundary for early stopping.

    • Main Results:

    • The proposed method successfully maintains the nominal type I error rate, even with significant patient population drift.
    • A modest reduction in patients assigned to the inferior treatment arm is achievable when a true treatment difference exists.
    • The adaptive design results in smaller increases in total sample size compared to nonadaptive designs, especially with large treatment effects.

    Conclusions:

    • Responsive adaptive designs are potentially useful for clinical trials, particularly when large treatment effects are anticipated.
    • Stratified randomization and analysis are crucial to mitigate bias due to time trends in patient characteristics.
    • Further research is needed, considering limitations like outcome observation delays, to optimize adaptive design implementation.